The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nelson, B. J.
Right arrow Articles by Nacy, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nelson, B. J.
Right arrow Articles by Nacy, C. A.

The Journal of Immunology, Vol 146, Issue 6 1849-1857, Copyright © 1991 by American Association of Immunologists


ARTICLES

Differential susceptibility of activated macrophage cytotoxic effector reactions to the suppressive effects of transforming growth factor-beta 1

BJ Nelson, P Ralph, SJ Green and CA Nacy
Department of Cellular Immunology, Walter Reed Army Institute of Research, Washington, DC 20307-5100.

We examined the effects of TGF-beta 1 on induction of several activated macrophage antimicrobial activities against the protozoan parasite Leishmania, and on induction of tumoricidal activity against the fibrosarcoma tumor target 1023. TGF-beta by itself did not affect the viability of either the intracellular or extracellular target in concentrations up to 200 ng/ml. As little as 1 ng/ml TGF-beta, however, suppressed more than 70% of the intracellular killing activity of macrophages treated with lymphokines. In contrast, more than 100 ng/ml TGF-beta was required to suppress intracellular killing by cells activated with an equivalent amount of recombinant IFN-gamma. Addition of TGF-beta for up to 30 min after exposure to activation factors significantly reduced macrophage killing of intracellular parasites. Pretreatment of macrophages with TGF-beta was even more effective: treatment of cells with TGF-beta for 4 h before addition of activation factors abolished all macrophage intracellular killing activity. Regardless of treatment sequence, however, TGF-beta had absolutely no effect, at any concentration tested, on activated macrophage resistance to infection induced by lymphokines or by the cooperative interaction of IFN-gamma and IL-4. Effects of TGF-beta on tumoricidal activity of activated macrophages was intermediate to that of its effects on intracellular killing or resistance to infection. Lymphokine-induced tumor cytotoxicity was marginally (25%) affected by TGF-beta; 200 ng/ml was able to suppress IFN-gamma-induced tumoricidal activity by 40%. Thus, TGF-beta dramatically suppressed certain activated macrophage cytotoxic effector reactions, but was only partially or not at all effective against others, even when the same activation agent (IFN- gamma) was used. The biochemical target for TGF-beta suppressive activity in these reactions may be the pathway for nitric oxide production from L-arginine, because TGF-beta also inhibited the generation of nitric oxide by cytokine-activated macrophages.


This article has been cited by other articles:


Home page
J. Immunol.Home page
C. M. Bosio, H. Bielefeldt-Ohmann, and J. T. Belisle
Active Suppression of the Pulmonary Immune Response by Francisella tularensis Schu4
J. Immunol., April 1, 2007; 178(7): 4538 - 4547.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
H. Takaki, Y. Minoda, K. Koga, G. Takaesu, A. Yoshimura, and T. Kobayashi
TGF-beta1 suppresses IFN-gamma-induced NO production in macrophages by suppressing STAT1 activation and accelerating iNOS protein degradation.
Genes Cells, August 1, 2006; 11(8): 871 - 882.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. L. M. Wanderley, M. E. C. Moreira, A. Benjamin, A. C. Bonomo, and M. A. Barcinski
Mimicry of Apoptotic Cells by Exposing Phosphatidylserine Participates in the Establishment of Amastigotes of Leishmania (L) amazonensis in Mammalian Hosts
J. Immunol., February 1, 2006; 176(3): 1834 - 1839.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. Murano, X. Xiong, N. Murano, J. L. Salzer, J. J. Lafaille, and V. K. Tsiagbe
Latent TGF-{beta}1-transduced CD4+ T cells suppress the progression of allergic encephalomyelitis
J. Leukoc. Biol., January 1, 2006; 79(1): 140 - 146.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. Eriksson, S. K. Meadows, C. R. Wira, and C. L. Sentman
Unique phenotype of human uterine NK cells and their regulation by endogenous TGF-{beta}
J. Leukoc. Biol., September 1, 2004; 76(3): 667 - 675.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
L. Gorelik, S. Constant, and R. A. Flavell
Mechanism of Transforming Growth Factor {beta}-induced Inhibition of T Helper Type 1 Differentiation
J. Exp. Med., June 3, 2002; 195(11): 1499 - 1505.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. C. Melby, B. Chandrasekar, W. Zhao, and J. E. Coe
The Hamster as a Model of Human Visceral Leishmaniasis: Progressive Disease and Impaired Generation of Nitric Oxide in the Face of a Prominent Th1-Like Cytokine Response
J. Immunol., February 1, 2001; 166(3): 1912 - 1920.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
L. H. Kasper and D. Buzoni-Gatel
Ups and Downs of Mucosal Cellular Immunity against Protozoan Parasites
Infect. Immun., January 1, 2001; 69(1): 1 - 8.
[Full Text] [PDF]


Home page
J. Immunol.Home page
K. M. Drescher, P. D. Murray, X. Lin, J. A. Carlino, and M. Rodriguez
TGF-{beta}2 Reduces Demyelination, Virus Antigen Expression, and Macrophage Recruitment in a Viral Model of Multiple Sclerosis
J. Immunol., March 15, 2000; 164(6): 3207 - 3213.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
A. Coste, J.-P. Lefaucheur, Q.-P. Wang, E. Lesprit, F. Poron, R. Peynegre, and E. Escudier
Expression of the Transforming Growth Factor {beta} Isoforms in Inflammatory Cells of Nasal Polyps
Arch Otolaryngol Head Neck Surg, December 1, 1998; 124(12): 1361 - 1366.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Z. Chen, G. M. Hochwald, C. Huang, G. Dakin, H. Tao, C. Cheng, W. J. Simmons, G. Dranoff, and G. J. Thorbecke
Gene therapy in allergic encephalomyelitis using myelin basic protein-specific T cells engineered to express latent transforming growth factor-beta 1
PNAS, October 13, 1998; 95(21): 12516 - 12521.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
E. Bohn, E. Schmitt, C. Bielfeldt, A. Noll, R. Schulte, and I. B. Autenrieth
Ambiguous Role of Interleukin-12 in Yersinia enterocolitica Infection in Susceptible and Resistant Mouse Strains
Infect. Immun., May 1, 1998; 66(5): 2213 - 2220.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Takeuchi, P. Alard, and J. W. Streilein
TGF-{beta} Promotes Immune Deviation by Altering Accessory Signals of Antigen-Presenting Cells
J. Immunol., February 15, 1998; 160(4): 1589 - 1597.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
M Barral-Netto, A Barral, C. Brownell, Y. Skeiky, L. Ellingsworth, D. Twardzik, and S. Reed
Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism
Science, July 24, 1992; 257(5069): 545 - 548.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1991 by The American Association of Immunologists, Inc. All rights reserved.